Herbal Home remedies

Toned shoulders gives the appearance of a smaller waist.  Try these simple exercises to strengthen, tone, and define your shoulders.  Stand with your feet shoulder width apart.  Slightly bend your knees, tuck your pelvis under, and keep your back straight.  Hold 2-3 lb. weights in front of your upper thighs.  With straight arms bring them both up at the same time lifting them no higher than shoulder height (i.e., your arms should be parallel to the ground).  Do 15-20 reps.  With your stance in the same position as the first exercise, start with your arms at your sides.  At the same time lift both arms out to the side no higher than shoulder height.  Do 15-20 reps.  Work up to 2-3 sets of each exercise.

Did you know that you can tone your abs while you’re pregnant without doing harmful situps?  Try this simple pregnancy exercise to tone your tummy.

Standing lift your left leg and touch your heal with your right hand.  Repeat 15-20 reps then switch sides (i.e. left hand to right heal).  Work up to 3 sets on each leg.

Benefits: Tones your waist and inner thighs

The most frequently asked question I have by moms is how to lose the baby bulge.  I highly recommend boosting your cardio, meaning get your heart rate up and break a sweat.  When you increase your cardio and get your heart rate up you will burn more calories.  A great exercise to get your hear rate up is kickboxing.  Another benefit of kickboxing is it tones your waist, thighs, hips and buttocks.  For indoor workouts check out my postnatal DVD’s “Stroller Workout for Moms” and “Total Body Toning” - they both have kickboxing. For a direct link click here: http://fitbysara.com/products.php

If you’re looking to lose weight afer having a baby, climb stairs!  Stairs will increase your heart rate, tone your thighs and buttocks and help you lose weight.  Here’s a simple routine: Powerwalk for 10 min., climb a staircase of 40-50 steps up and down a total of 10 times.  Alternate between the powerwalk and the stairs for a total of 30-40 min..  You’ll feel the burn and you’ll love the results!

Baxter says trial on new flu shot promising

Baxter International Inc., working to modernize the production of influenza vaccines, this morning said its seasonal flu product is showing "strong antibody responses and good tolerability" in an early stage clinical trial in humans.

Although Baxter is still several years from winning approval of the product, the study shows Baxter's reformulated seasonal flu vaccine is tolerable. In late 2004, Baxter had to suspend final-stage human sudy of its seasonal flu vaccine because it was causing fevers in some patients.

The Deerfield-based medical product giant is trying to develop a flu vaccine produced with cell tissues, which is a method that would allow manufacturers to quickly brew vaccine by the vat and likely eliminate shortages like the one that rattle U.S. consumers and health-care providers from time to time.
The cell-based approach is a sharp contrast to the tedious, 1940s method still used today that involves hand-processing millions of chicken eggs in labs. For each dosers shine a light through the shell of an egg to find the fluid surrounding an embryo, inject a strain of the flu virus and let it incubate for several months.

The current method is a long months-long process fraught with risk, while cell-based vaccines are more consistent and could be produced in as little as nine to 12 weeks.

In the latest clinical trial, Baxter said more than 900 patients were studied. Baxter said the preliminary data show its cell-based seasonal influenza vaccine's "tolerability profile" to be similar to egg-based seasonal flu vaccines on the market. There were, however, some side effects that included headaches and some injection site reactions, Baxter said.

Baxter is building momentum for its vaccines business. The company is also in the final stages of testing for a vaccine against strains of the Avian influenza, also known as the bird flu and is working with governments around the world interested in stockpiling the product in the event of a pandemic outbreak. Chicago Tribune